Point72 Asset Management
XERS icon

Point72 Asset Management’s Xeris Biopharma Holdings XERS Stock Holding History

Point72 Asset Management’s Portfolio XERS Stock Details XERS Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
2025
Q2 		$211K Sell
2025
Q1 		$485K Buy
2023
Q4 		– Sell
2023
Q3 		$1.22M Buy
2023
Q1 		– Sell
2022
Q4 		$79.8K Buy
2020
Q3 		– Sell
2020
Q2 		$618K Buy
2018
Q3 		– Sell
2018
Q2 		$95K Buy